Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without diabetes represents one of the most unique and challenging decisions in years ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Metformin is a drug used to treat type 2 diabetes mellitus. While some may notice fallout or thinning when taking this ...

GLP-1 drugs spiked in popularity and price over the past few years, leaving the door open for illegal pharmacies to try and ...

18, 2024 — Until now, scientists have been unable to determine how metformin, a Type 2 diabetes medication that lowers ... a new injectable weight-loss drug, reduced the risk of diabetes in ...

The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials decided to indefinitely pause covering their use for weight loss patients ...

Eighty percent of doctors in a Medscape survey answered no when asked, “Is enough known about obesity meds’ risk to ...

A patient came into the emergency department complaining about nausea, vomiting and abdominal pain. It was something more ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Recent medical research reveals striking differences between surgical and pharmaceutical approaches to weight ... loss at 10 ...